encorafenibvemurafenibbinimetinibcobimetinibdabrafenibNIVO+RELAatezolizumabnivolumabtrametinibNIVO+IPI
…TEZO, atezolizumab; BINI, binimetinib; COBI, cobimetinib; ENCO, encorafenib; ESS, effective sample size; DAB, dabrafenib; NIVO, nivolumab; …
7articles mentioning drugs
56drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Nivo ×
Nivo
This drug is selected. Its supporting articles are shown below.
Articles mentioning Nivo
7 articles · page 1 of 1sorafeniblenvatinibnivolumabipilimumabNIVOSORIPILEN
… trial assessing nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in the first-line set…
RELAnivolumabNIVOrelatlimabipilimumabbasal cell carcinoma
… be enrolled in the first stage. If ≥2 patients respond to NIVO+RELA, the study will continue enrollment for a total of 20 patients.…
nivolumabipilimumabPembropembrolizumab-basedNivoNivo+IpiIpiNSCLC
…emotherapy, pembrolizumab-based chemoimmunotherapy (Pembro) and nivolumab plus ipilimumab with or without two cycles of platinum-doublet …
nivolumabnivoRP1nivo-related
…notherapy. The IGNYTE trial showed that RP1 in combination with nivolumab (nivo) demonstrated clinically meaningful, durable responses (o…
ipilimumabnivolumabIPINIVONSCLCmetastatic non-small cell lung cancer
…is limitation, we evaluated the efficacy and safety of combined ipilimumab and nivolumab (IPI/NIVO) with subablative radiotherapy (RT) in …
NivolumabNivocolorectal cancerCRCWCG Institutional Review Board
…analyzed across multiple timepoints to resolve kinetics.Results Nivolumab induced three distinct response kinetics across the CRC patient…